Funding round pulls in $8.5M for Ocular Therapeutix

06/11/2013 | Medical Device & Diagnostic Industry online

Ocular Therapeutix has secured $8.5 million in a funding round, according to a regulatory filing. The Bedford, Mass.-based company is awaiting premarket approval from the FDA for its ReSure Sealant, a biocompatible hydrogel used to help protect corneal incisions in patients who have undergone intraocular lens placement or cataract procedures.

View Full Article in:

Medical Device & Diagnostic Industry online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR